Cargando…

Linac-Based Ultrahypofractionated Partial Breast Irradiation (APBI) in Low-Risk Breast Cancer: First Results of a Monoinstitutional Observational Analysis

SIMPLE SUMMARY: The subject of this trial was the introduction of adjuvant APBI. The radiation dose in the target volume and in organs at risk were evaluated retroactively, as was the acute toxicity. The exposure of the organs at risk was very low. Two out of three irradiated patients remained witho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Merten, Roland, Fischer, Mirko, Kopytsia, Gennadii, Wichmann, Jörn, Lange, Tim, Knöchelmann, Anne Caroline, Becker, Jan-Niklas, Klapdor, Rüdiger, Hinrichs, Jan, Bremer, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954287/ https://www.ncbi.nlm.nih.gov/pubmed/36831481 http://dx.doi.org/10.3390/cancers15041138

Ejemplares similares

Accelerated Partial Breast Irradiation (APBI): Where Are We Now?
por: Goldberg, Mira, et al.
Publicado: (2020)

Accelerated Partial Breast Irradiation (APBI): A review of available techniques
por: Njeh, Christopher F, et al.
Publicado: (2010)

Brachytherapy in accelerated partial breast irradiation (APBI) – review of treatment methods
por: Skowronek, Janusz, et al.
Publicado: (2012)

Adoption of Ultrahypofractionated Radiation Therapy in Patients With Breast Cancer
por: Corrigan, Kelsey L., et al.
Publicado: (2021)

Comparison of 2D- and 3D-guided implantation in accelerated partial breast irradiation (APBI)
por: Cholewka, Agnieszka, et al.
Publicado: (2010)

Dosimetric evaluation of photons versus protons in postmastectomy planning for ultrahypofractionated breast radiotherapy
por: Oonsiri, Puntiwa, et al.
Publicado: (2022)

Radiation-induced breast angiosarcoma: report of two patients after accelerated partial breast irradiation (APBI) and review of the literature
por: Cozzi, Salvatore, et al.
Publicado: (2021)

Accelerated Adaptation of Ultrahypofractionated Radiation Therapy for Breast Cancer at the Time of the COVID-19 Pandemic
por: Machiels, M., et al.
Publicado: (2021)

Case report: Ultrahypofractionated palliative breast radiotherapy for a fungating invasive mammary carcinoma
por: Hong, Yejun, et al.
Publicado: (2023)

One-Year Toxicity of Ultrahypofractionated Breast Radiotherapy (+/- Sequential Boost) and a Survey of Patient Experience
por: Nicholson, J., et al.
Publicado: (2022)

Whole breast irradiation vs. APBI using multicatheter brachytherapy in early breast cancer – simulation of treatment costs based on phase 3 trial data
por: Harat, Aleksandra, et al.
Publicado: (2016)

Simultaneous couch and gantry dynamic arc rotation (CG‐Darc) in the treatment of breast cancer with accelerated partial breast irradiation (APBI): a feasibility study
por: Popescu, Carmen C., et al.
Publicado: (2013)

The importance of the implant quality in APBI – Gliwice experience. Dosimetric evaluation
por: Cholewka, Agnieszka, et al.
Publicado: (2013)

WBRT vs. APBI: an interim report of patient satisfaction and outcomes
por: Bitter, Samantha M., et al.
Publicado: (2016)

Clinical outcomes, toxicity, and cosmesis in breast cancer patients with close skin spacing treated with accelerated partial breast irradiation (APBI) using multi-lumen/catheter applicators
por: Akhtari, Mani, et al.
Publicado: (2016)

The Proper Ki-67 Cut-Off in Hormone Responsive Breast Cancer: A Monoinstitutional Analysis with Long-Term Follow-Up
por: Lombardi, Augusto, et al.
Publicado: (2021)

Prostate Ultrahypofractionation – Rising to Challenges Presents Opportunities in the COVID-19 Era
por: Griffiths, W., et al.
Publicado: (2021)

MRI-Guided Radiation Therapy for Prostate Cancer: The Next Frontier in Ultrahypofractionation
por: Benitez, Cecil M., et al.
Publicado: (2023)

Second breast-conserving therapy with interstitial brachytherapy (APBI) as a salvage treatment in ipsilateral breast tumor recurrence: a retrospective study of 40 patients
por: Cozzi, Salvatore, et al.
Publicado: (2019)

Evaluation of three APBI techniques under NSABP B‐39 guidelines
por: Scanderbeg, Daniel, et al.
Publicado: (2009)

On the feasibility of treating to a 1.5 cm PTV with a commercial single-entry hybrid applicator in APBI breast brachytherapy
por: Gifford, Kent A., et al.
Publicado: (2012)

The Combination of Carmustine Wafers and Fotemustine in Recurrent Glioblastoma Patients: A Monoinstitutional Experience
por: Lombardi, Giuseppe, et al.
Publicado: (2014)

Multi-institutional retrospective analysis of ultrahypofractionated radiotherapy for Japanese prostate cancer patients
por: Ishiyama, Hiromichi, et al.
Publicado: (2021)

PO-1456 Impact of COVID-19 pandemic to radiotherapy activities: a monoinstitutional evaluation
por: Patani, F., et al.
Publicado: (2021)

Three-year outcomes of a once daily fractionation scheme for accelerated partial breast irradiation (APBI) using 3-D conformal radiotherapy (3D-CRT)
por: Goyal, Sharad, et al.
Publicado: (2013)

Feasibility of MR-guided ultrahypofractionated radiotherapy in 5, 2 or 1 fractions for prostate cancer
por: Mohajer, Jonathan, et al.
Publicado: (2020)

Ultrahypofractionation of localized prostate cancer: Statement from the DEGRO working group prostate cancer
por: Wolf, Frank, et al.
Publicado: (2020)

Ultrahypofractionated Radiotherapy versus Conventional to Moderate Hypofractionated Radiotherapy for Clinically Localized Prostate Cancer
por: Yamazaki, Hideya, et al.
Publicado: (2021)

A randomized controlled trial testing a hyaluronic acid spacer injection for skin toxicity reduction of brachytherapy accelerated partial breast irradiation (APBI): a study protocol
por: Struik, Gerson M., et al.
Publicado: (2018)

Pathologic Response to Neoadjuvant Sequential Chemoradiation Therapy in Locally Advanced Breast Cancer: Preliminary, Translational Results from the French Neo-APBI-01 Trial
por: To, Nhu Hanh, et al.
Publicado: (2023)

A-Site Cation Dependence of Self-Healing in Polycrystalline APbI(3) Perovskite Films
por: Singh, Pallavi, et al.
Publicado: (2023)

Monoinstitutional real world experience in management of Vinflunine as second line therapy for transitional cell carcinoma of the urothelium
por: Schinzari, Giovanni, et al.
Publicado: (2018)

Ipilimumab and Stereotactic Radiosurgery with CyberKnife(®) System in Melanoma Brain Metastases: A Retrospective Monoinstitutional Experience
por: Borzillo, Valentina, et al.
Publicado: (2021)

FDG-PET/CT in the Radiotherapy Treatment Planning of Locally Advanced Anal Cancer: A Monoinstitutional Experience
por: Di Carlo, Clelia, et al.
Publicado: (2021)

Handling and standardization of EBUS needle aspiration in NSCLC patients: The value of the cell block, a monoinstitutional experience
por: Parente, Paola, et al.
Publicado: (2022)

Adjuvant chemoradiotherapy in elderly patients with head and neck cancer: a monoinstitutional, two-to-one pair-matching analysis
por: Mayer, Arnulf, et al.
Publicado: (2022)

Long-Term Clinical Outcome after Treatment for High-Grade Cervical Lesions: A Retrospective Monoinstitutional Cohort Study
por: Del Mistro, Annarosa, et al.
Publicado: (2015)

Outcomes of ALK positive lung cancer patients treated with crizotinib or second-generation ALK inhibitor: a monoinstitutional experience
por: De Carlo, Elisa, et al.
Publicado: (2018)

Comparison of toxicities between ultrahypofractionated radiotherapy versus brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2022)

Pei regimen: a therapeutic option in small cell lung cancer? A retrospective monoinstitutional analysis of 46 consecutive cases
por: Boni, Corrado, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7vcqtdbduj34689uquat3pjoli